Interactions between the extracellular matrix and inflammation during viral myocarditis

Immunobiology

Volumn 217, Issue 5, 2012, Pages 503-510

  Papageorgiou, Anna Pia ^a   Heymans, Stephane ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Extracellular matrix; Inflammation; Myocarditis

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; CYSTEINE RICH PROTEIN 61; GELATINASE A; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; MACROPHAGE ELASTASE; NEUTROPHIL COLLAGENASE; OSTEOPONTIN; TENASCIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UROKINASE RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1;

ADENOVIRUS; CONGESTIVE CARDIOMYOPATHY; COXSACKIE VIRUS B; CYTOKINE RELEASE; DISEASE SEVERITY; EPSTEIN BARR VIRUS; EXTRACELLULAR MATRIX; HEART FAILURE; HEART FUNCTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN PARVOVIRUS B19; INFLAMMATION; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SUDDEN DEATH; VIRUS CELL INTERACTION; VIRUS MYOCARDITIS; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MYOCARDITIS; VIRUS DISEASES;

EID: 84858797099     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.07.011     Document Type: Review

References (83)

1. Bai T., Chen C.C., et al. Matricellular protein CCN1 activates a proinflammatory genetic program in murine macrophages. J. Immunol. 2010, 184(6):3223-3232.
2. Banerjee I., Fuseler J.W., et al. Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. Am. J. Physiol. Heart Circ. Physiol. 2007, 293(3):H1883-H1891.
3. Blailock Z.R, Rabin E.R., et al. Adenovirus myocarditis in mice. An electron microscopic study. Exp. Mol. Pathol. 1968, 9(1):84-96.
4. Blauwet L.A., Cooper L.T. Myocarditis. Prog. Cardiovasc. Dis. 2010, 52(4):274-288.
5. Bowles N.E, Ni J., et al. Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J. Am. Coll. Cardiol. 2003, 42(3):466-472.
6. Burrage P.S., Brinckerhoff C.E. Molecular targets in osteoarthritis: metalloproteinases and their inhibitors. Curr. Drug Targets 2007, 8(2):293-303.
7. Chen C.C, Lau L.F. Deadly liaisons: fatal attraction between CCN matricellular proteins and the tumor necrosis factor family of cytokines. J. Cell Commun. Signal. 2009, 4(1):63-69.
8. Chen C.C., Lau L.F. Functions and mechanisms of action of CCN matricellular proteins. Int. J. Biochem. Cell Biol. 2009, 41(4):771-783.
9. Cheung C., Marchant D., et al. Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice. Circulation 2008, 117(12):1574-1582.
10. Clutterbuck A.L., Asplin K.E., et al. Targeting matrix metalloproteinases in inflammatory conditions. Curr. Drug Targets 2009, 10(12):1245-1254.
11. Crocker S.J, Frausto R.F., et al. Amelioration of coxsackievirus B3-mediated myocarditis by inhibition of tissue inhibitors of matrix metalloproteinase-1. Am. J. Pathol. 2007, 171(6):1762-1773.
12. D'Ambrosio A., Patti G., et al. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 2001, 85(5):499-504.
13. Dean R.A, Cox J.H., et al. Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx. Blood 2008, 112(8):3455-3464.
14. Dobaczewski M., Gonzalez-Quesada C., et al. The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J. Mol. Cell. Cardiol. 2010, 48(3):504-511.
15. Endo K., Takino T., et al. Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. J. Biol. Chem. 2003, 278(42):40764-40770.
16. Erickson A.C., Couchman J.R. Still more complexity in mammalian basement membranes. J. Histochem. Cytochem. 2000, 48(10):1291-1306.
17. Frangogiannis N.G The immune system and cardiac repair. Pharmacol. Res. 2008, 58(2):88-111.
18. Frangogiannis N.G., Ren G., et al. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation 2005, 111(22):2935-2942.
19. Haro H., Crawford H.C., et al. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. J. Clin. Invest. 2000, 105(2):143-150.
20. Heymans S. Myocarditis and heart failure: need for better diagnostic, predictive, and therapeutic tools. Eur. Heart J. 2007, 28(11):1279-1280.
21. Heymans S., Luttun A., et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat. Med. 1999, 5(10):1135-1142.
22. Heymans S., Pauschinger M., et al. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis. Circulation 2006, 114(6):565-573.
23. Huber S.A Depletion of gammadelta+ T cells increases CD4+ FoxP3 (T regulatory) cell response in coxsackievirus B3-induced myocarditis. Immunology 2009, 127(4):567-576.
24. Hynes R.O. The extracellular matrix: not just pretty fibrils. Science 2009, 326(5957):1216-1219.
25. Imai K., Hiramatsu A., et al. Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem. J. 1997, 322(Pt 3):809-814.
26. Imanaka-Yoshida K., Hiroe M., et al. Tenascin-C is a useful marker for disease activity in myocarditis. J. Pathol. 2002, 197(3):388-394.
27. Jourdan-Lesaux C., Zhang J., et al. Extracellular matrix roles during cardiac repair. Life Sci. 2010, 87(13-14):391-400.
28. Karsdal M.A., Larsen L., et al. Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J. Biol. Chem. 2002, 277(46):44061-44067.
29. Kelly K.A, Allport J.R., et al. SPARC is a VCAM-1 counter-ligand that mediates leukocyte transmigration. J. Leukoc. Biol. 2007, 81(3):748-756.
30. Kenne E., Soehnlein O., et al. Immune cell recruitment to inflammatory loci is impaired in mice deficient in basement membrane protein laminin alpha4. J. Leukoc. Biol. 2010, 88(3):523-528.
31. Kim H.E., Dalal S.S., et al. Disruption of the myocardial extracellular matrix leads to cardiac dysfunction. J. Clin. Invest. 2000, 106(7):857-866.
32. Koskivirta I., Kassiri Z., et al. Mice with tissue inhibitor of metalloproteinases 4 (Timp4) deletion succumb to induced myocardial infarction but not to cardiac pressure overload. J. Biol. Chem. 2010, 285(32):24487-24493.
33. Lamy L., Foussat A., et al. Interactions between CD47 and thrombospondin reduce inflammation. J. Immunol. 2007, 178(9):5930-5939.
34. Leask A. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ. Res. 2010, 106(11):1675-1680.
35. LeLeiko R.M., Bower D.J., et al. MRSA-associated bacterial myocarditis causing ruptured ventricle and tamponade. Cardiology 2008, 111(3):188-190.
36. Li K., Xu W., et al. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis. Circ. Res. 2009, 105(4):353-364.
37. Marchant D., McManus B.M. Matrix metalloproteinases in the pathogenesis of viral heart disease. Trends Cardiovasc. Med. 2009, 19(1):21-26.
38. Mateo V., Brown E.J., et al. Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization. Blood 2002, 100(8):2882-2890.
39. McGuire J.K., Li Q., et al. Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. Am. J. Pathol. 2003, 162(6):1831-1843.
40. McQuibban G.A, Gong J.H., et al. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 2002, 100(4):1160-1167.
41. Medina C., Radomski M.W. Role of matrix metalloproteinases in intestinal inflammation. J. Pharmacol. Exp. Ther. 2006, 318(3):933-938.
42. Morimoto S., Imanaka-Yoshida K., et al. Diagnostic utility of tenascin-C for evaluation of the activity of human acute myocarditis. J. Pathol. 2005, 205(4):460-467.
43. Muroski M.E., Roycik M.D., et al. Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis. Curr. Pharm. Biotechnol. 2008, 9(1):34-46.
44. Nahrendorf M., Swirski F.K., et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 2007, 204(12):3037-3047.
45. Nourshargh S., Hordijk P.L., et al. Breaching multiple barriers: leukocyte motility through venular walls and the interstitium. Nat. Rev. Mol. Cell Biol. 2010, 11(5):366-378.
46. Orlando S., Sironi M., et al. Role of metalloproteases in the release of the IL-1 type II decoy receptor. J. Biol. Chem. 1997, 272(50):31764-31769.
47. Park Y.W., Kang Y.M., et al. Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis. Am. J. Pathol. 2004, 165(6):2087-2098.
48. Pauschinger M., Rutschow S., et al. Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response. Eur. J. Heart Fail. 2005, 7(4):444-452.
49. Podgorski I., Linebaugh B.E., et al. Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis. Am. J. Pathol. 2009, 175(3):1255-1269.
50. Rebres R.A, Kajihara K., et al. Novel CD47-dependent intercellular adhesion modulates cell migration. J. Cell. Physiol. 2005, 205(2):182-193.
51. Reijerkerk A., Kooij G., et al. Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells. FASEB J. 2006, 20(14):2550-2552.
52. Ritzman A.M, Hughes-Hanks J.M., et al. The chemokine receptor CXCR2 ligand KC (CXCL1) mediates neutrophil recruitment and is critical for development of experimental Lyme arthritis and carditis. Infect. Immun. 2010, 78(11):4593-4600.
53. Rosenberg G.A. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol. 2009, 8(2):205-216.
54. Rother M., Krohn S., et al. Matricellular signaling molecule CCN1 attenuates experimental autoimmune myocarditis by acting as a novel immune cell migration modulator. Circulation 2010, 122(25):2688-2698.
55. Said N.A., Elmarakby A.A., et al. SPARC ameliorates ovarian cancer-associated inflammation. Neoplasia 2008, 10(10):1092-1104.
56. Santos-Martinez M.J, Medina C., et al. Role of metalloproteinases in platelet function. Thromb. Res. 2008, 121(4):535-542.
57. Sasaki T., Larsson H., et al. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity. J. Mol. Biol. 2000, 301(5):1179-1190.
58. Schellings M.W, Vanhoutte D., et al. Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction. J. Exp. Med. 2009, 206(1):113-123.
59. Schonbeck U., Mach F., et al. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J. Immunol. 1998, 161(7):3340-3346.
60. Schroen B., Heymans S., et al. Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy. Circ. Res. 2004, 95(5):515-522.
61. Sheu B.C., Hsu S.M., et al. A novel role of metalloproteinase in cancer-mediated immunosuppression. Cancer Res. 2001, 61(1):237-242.
62. Shi Y., Chen C., et al. Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo. J. Am. Coll. Cardiol. 2009, 53(14):1219-1226.
63. Siwik D.A., Chang D.L., et al. Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ. Res. 2000, 86(12):1259-1265.
64. Soares M.B, de Lima R.S., et al. Gene expression changes associated with myocarditis and fibrosis in hearts of mice with chronic chagasic cardiomyopathy. J. Infect. Dis. 2010, 202(3):416-426.
65. Soehnlein O., Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat. Rev. Immunol. 2010, 10(6):427-439.
66. Sorokin L. The impact of the extracellular matrix on inflammation. Nat. Rev. Immunol. 2010, 10(10):712-723.
67. Swinnen M., Vanhoutte D., et al. Absence of thrombospondin-2 causes age-related dilated cardiomyopathy. Circulation 2009, 120(16):1585-1597.
68. Szalay G., Sauter M., et al. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host. Circ. Res. 2009, 104(7):851-859.
69. Turowski P., Martinelli R., et al. Phosphorylation of vascular endothelial cadherin controls lymphocyte emigration. J. Cell Sci. 2008, 121(Pt 1):29-37.
70. Vallejo A.N., Mugge L.O., et al. Central role of thrombospondin-1 in the activation and clonal expansion of inflammatory T cells. J. Immunol. 2000, 164(6):2947-2954.
71. Van Lint P., Libert C. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J. Leukoc. Biol. 2007, 82(6):1375-1381.
72. Vanhoutte D., Heymans S. TIMPs and cardiac remodeling: embracing the MMP-independent-side of the family. J. Mol. Cell. Cardiol. 2010, 48(3):445-453.
73. Wang S., Voisin M.B., et al. Venular basement membranes contain specific matrix protein low expression regions that act as exit points for emigrating neutrophils. J. Exp. Med. 2006, 203(6):1519-1532.
74. Westermann D., Savvatis K., et al. Immunomodulation and matrix metalloproteinases in viral myocarditis. J. Mol. Cell. Cardiol. 2010, 48(3):468-473.
75. Workman G., Sage E.H. Identification of a sequence in the matricellular protein sparc that interacts with the scavenger receptor stabilin-1. J. Cell. Biochem. 2011.
76. Wu C., Ivars F., et al. Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain. Nat. Med. 2009, 15(5):519-527.
77. Yabkowitz R., Dixit V.M., et al. Activated T-cell adhesion to thrombospondin is mediated by the alpha 4 beta 1 (VLA-4) and alpha 5 beta 1 (VLA-5) integrins. J. Immunol. 1993, 151(1):149-158.
78. Yadav R., Larbi K.Y., et al. Migration of leukocytes through the vessel wall and beyond. Thromb. Haemost. 2003, 90(4):598-606.
79. Yajima T., Knowlton K.U. Viral myocarditis: from the perspective of the virus. Circulation 2009, 119(19):2615-2624.
80. Yu Q., Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 2000, 14(2):163-176.
81. Yue Y., Gui J., et al. Gene therapy with CCL2 (MCP-1) mutant protects CVB3-induced myocarditis by compromising Th1 polarization. Mol. Immunol. 2010, 48(4):706-713.
82. Zamiri P., Masli S., et al. Thrombospondin plays a vital role in the immune privilege of the eye. Invest. Ophthalmol. Vis. Sci. 2005, 46(3):908-919.
83. Zhang Z.C, Li S.J., et al. Microarray analysis of extracellular matrix genes expression in myocardium of mouse with Coxsackie virus B3 myocarditis. Chin. Med. J. (Engl.) 2004, 117(8):1228-1231.